|
In March 2007, Novartis agreed to stop selling Zelnorm at the request of FDA.
Serious Adverse Effects
- Heart Attack
- Stroke
- Severe Chest Pain Leading to Heart Attack
- Life-Threatening Cardiovascular Side Effects
Zelnorm (generic: tegaserod maleate), manufactured by Novartis Pharmaceuticals, is a prescription medication approved for short term treatment of women with irritable bowel syndrome with constipation, and for patients younger than 65 years with chronic constipation.
In March 2007, Novartis agreed to stop selling Zelnorm at the request of FDA.
In a recent analysis of 29 clinical studies of Zelnorm assessing the chance of side effects on the heart and blood vessels, patients were randomly assigned either Zelnorm or a sugar pill. Participants who were given Zelnorm were more likely to experience life-threatening cardiovascular side effects including heart attacks leading to death, severe heart chest pain which can quickly turn into heart attacks, and strokes.
In March 2007, Novartis agreed to stop selling Zelnorm at the request of FDA.
FDA has indicated to Novartis a willingness to consider limited re-introduction of Zelnorm at a later date if a population of patients can be identified in whom the benefits of the drug outweigh the risks.
In March 2007, Novartis agreed to stop selling Zelnorm at the request of FDA.
To view the FDA Advisory, click this link:www.fda.gov/cder/drug/advisory/tegaserod.htm
If you have taken Zelnorm and have suffered any of these problems, contact us today.
In March 2007, Novartis agreed to stop selling Zelnorm at the request of FDA.
Your time may be short to collect compensatory or punitive damages for your serious injuries. If you, your family or someone you know has been injured, email us now for a free, private consultation. Knowledge is power - we'd like to help you!
CLICK HERE to contact us today, or send an email to Info@HelpingTheInjured.com
|
